Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Spratt

Showing results (271-280 of 666) with videos related to

Pageof 67
Sort By:
Future Oncology (London, England)|April 29, 2026
Real-world clinical outcomes in patients with biochemical recurrence after local therapy for non-metastatic prostate cancerNeal D Shore, Nasreen Khan, Rana R McKay, et al.
Molecular Pharmaceutics|February 19, 2020
Detecting TRA-1-60 in Cancer via a Novel Zr-89 Labeled ImmunoPET Imaging AgentJordan M White, Akhila N Kuda-Wedagedara, Madison N Wicker, et al.
Future Medicinal Chemistry|January 11, 2024
Synthesis and evaluation of 2,5-substituted pyrimidines as small-molecule gankyrin bindersDipti Kanabar, Emma I Kane, Tejashri Chavan, et al.
Expert Review of Anticancer Therapy|May 17, 2023
Lutetium-177 PSMA for the treatment of metastatic castrate resistant prostate cancer: a systematic reviewKanchi Patell, Matthew Kurian, Jorge A Garcia, et al.
Prostate Cancer and Prostatic Diseases|April 27, 2016
Radium-223 outcomes after multiple lines of metastatic castration-resistant prostate cancer therapy in clinical practice: implication of pre-treatment spinal epidural diseaseD E Spratt, J R Osborne, Z S Zumsteg, et al.
JCO Oncology Practice|May 20, 2025
Time to Treatment Initiation for the 30 Most Prevalent Cancer Types: Trends and Predictors of ChangeGianna J Dafflisio, Ming Wang, Xi Wang, et al.
European Journal of Medicinal Chemistry|May 26, 2011
Development of novel naphthalimide derivatives and their evaluation as potential melanoma therapeuticsUgir Hossain Sk, A S Prakasha Gowda, Melissa A Crampsie, et al.
European Urology|August 16, 2016
Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node CoverageDaniel E Spratt, Hebert A Vargas, Zachary S Zumsteg, et al.
Cell Reports|February 27, 2025
Translesion-synthesis-mediated bypass of DNA lesions occurs predominantly behind replication forks restarted by PrimPolAshna Dhoonmoon, Julia R Ambrose, Sonal Garg, et al.
Archives of Osteoporosis|March 5, 2026
Secondary fracture prevention after vertebral, femur or pelvic fracture at US academic medical centerPatrick Cacchio, Nicole Sagalla, Kenneth W Lyles, et al.
Pageof 67

Showing results (271-280 of 666) with videos related to

Sort By:
Pageof 67
Future Oncology (London, England)|April 29, 2026
Real-world clinical outcomes in patients with biochemical recurrence after local therapy for non-metastatic prostate cancerNeal D Shore, Nasreen Khan, Rana R McKay, et al.
Molecular Pharmaceutics|February 19, 2020
Detecting TRA-1-60 in Cancer via a Novel Zr-89 Labeled ImmunoPET Imaging AgentJordan M White, Akhila N Kuda-Wedagedara, Madison N Wicker, et al.
Future Medicinal Chemistry|January 11, 2024
Synthesis and evaluation of 2,5-substituted pyrimidines as small-molecule gankyrin bindersDipti Kanabar, Emma I Kane, Tejashri Chavan, et al.
Expert Review of Anticancer Therapy|May 17, 2023
Lutetium-177 PSMA for the treatment of metastatic castrate resistant prostate cancer: a systematic reviewKanchi Patell, Matthew Kurian, Jorge A Garcia, et al.
Prostate Cancer and Prostatic Diseases|April 27, 2016
Radium-223 outcomes after multiple lines of metastatic castration-resistant prostate cancer therapy in clinical practice: implication of pre-treatment spinal epidural diseaseD E Spratt, J R Osborne, Z S Zumsteg, et al.
JCO Oncology Practice|May 20, 2025
Time to Treatment Initiation for the 30 Most Prevalent Cancer Types: Trends and Predictors of ChangeGianna J Dafflisio, Ming Wang, Xi Wang, et al.
European Journal of Medicinal Chemistry|May 26, 2011
Development of novel naphthalimide derivatives and their evaluation as potential melanoma therapeuticsUgir Hossain Sk, A S Prakasha Gowda, Melissa A Crampsie, et al.
European Urology|August 16, 2016
Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node CoverageDaniel E Spratt, Hebert A Vargas, Zachary S Zumsteg, et al.
Cell Reports|February 27, 2025
Translesion-synthesis-mediated bypass of DNA lesions occurs predominantly behind replication forks restarted by PrimPolAshna Dhoonmoon, Julia R Ambrose, Sonal Garg, et al.
Archives of Osteoporosis|March 5, 2026
Secondary fracture prevention after vertebral, femur or pelvic fracture at US academic medical centerPatrick Cacchio, Nicole Sagalla, Kenneth W Lyles, et al.
Pageof 67